Preclinical Evaluation of Vaccines to Treat Opioid Use Disorders: How Close are We to a Clinically Viable Therapeutic?

The ongoing opioid crisis, now into its second decade, represents a global public health challenge. Moreover, the opioid crisis has manifested despite clinical access to three approved opioid use disorder medications: the full opioid agonist methadone, the partial opioid agonist buprenorphine, and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Townsend, E. Andrew, Banks, Matthew L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Leading Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223115/
https://www.ncbi.nlm.nih.gov/pubmed/32248427
http://dx.doi.org/10.1007/s40263-020-00722-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223115/
https://www.ncbi.nlm.nih.gov/pubmed/32248427
http://dx.doi.org/10.1007/s40263-020-00722-8

Ejemplares similares